ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10082
Vaccine NameFluMist Quadrivalent
Disease NameInfluenza (flu)
Disease ClassificationRespiratory
Virus NameInfluenza virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypeLive-attenuated
Vaccine StatusApproved
ManufacturerAstraZeneca plc
Year of Manufacturing2003
Manufacturing CountryCanada
Age2 - 49 years
DosageSingle dose
Administration RouteIntranasal
AdjuvantNA
Target StrainHemagglutinin
DescriptionEgg based
Approving OrganisationUS FDA
Collaborating OrganisationNA
Other CountriesNA
Trade NameTamiflu, Relenza
PMIDNA
Clinical Trial IDNA
Reference Linkhttps://www.cdc.gov/flu/prevent/flushot.htm
Additional Linkshttps://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm